Switch to:
Onyx Pharmaceuticals, Inc. (NAS:ONXX)
Interest Expense
\$-22.5 Mil (TTM As of Jun. 2013)

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Onyx Pharmaceuticals, Inc.'s interest expense for the three months ended in Jun. 2013 was \$-5.7 Mil. Its interest expense for the trailing twelve months (TTM) ended in Jun. 2013 was \$-22.5 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a companys Operating Income (EBIT) by its Interest Expense. Onyx Pharmaceuticals, Inc.'s Operating Income for the three months ended in Jun. 2013 was \$-47.5 Mil. Onyx Pharmaceuticals, Inc.'s Interest Expense for the three months ended in Jun. 2013 was \$-5.7 Mil. Onyx Pharmaceuticals, Inc. did not have earnings to cover the interest expense. The higher the ratio, the stronger the companys financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Definition

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Onyx Pharmaceuticals, Inc. Interest Expense for the trailing twelve months (TTM) ended in Jun. 2013 was -5.456 (Sep. 2012 ) + -5.659 (Dec. 2012 ) + -5.626 (Mar. 2013 ) + -5.712 (Jun. 2013 ) = \$-22.5 Mil.

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.

Explanation

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a companys Operating Income (EBIT) by its Interest Expense. The higher, the better.

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Onyx Pharmaceuticals, Inc.'s interest expense for the three months ended in Jun. 2013 was \$-5.7 Mil. Its operating income for the three months ended in Jun. 2013 was \$-47.5 Mil. And its Long-Term Debt for the three months ended in Jun. 2013 was \$180.7 Mil.

Onyx Pharmaceuticals, Inc.'s Interest Coverage for the quarter that ended in Jun. 2013 is calculated as

 Onyx Pharmaceuticals, Inc. did not have earnings to cover the interest expense.

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.

The higher the ratio, the stronger the companys financial strength is.

Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.

Onyx Pharmaceuticals, Inc. Annual Data

 Dec03 Dec04 Dec05 Dec06 Dec07 Dec08 Dec09 Dec10 Dec11 Dec12 Interest Expense 0.0 0.0 0.0 0.0 0.0 0.0 -6.9 -19.4 -20.2 -21.8

Onyx Pharmaceuticals, Inc. Quarterly Data

 Mar11 Jun11 Sep11 Dec11 Mar12 Jun12 Sep12 Dec12 Mar13 Jun13 Interest Expense -5.0 -5.0 -5.1 -5.1 -5.3 -5.4 -5.5 -5.7 -5.6 -5.7
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to \$400 per referral. ( Learn More)